comparemela.com

Latest Breaking News On - Y mabs therapeutics company profile - Page 1 : comparemela.com

Insider Selling: Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Insider Sells 35,000 Shares of Stock

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $12.03, for a total transaction of $421,050.00. Following the completion of the sale, the insider now directly owns 197,681 […]

Y-mAbs Therapeutics (NASDAQ:YMAB) Stock Price Up 7 5%

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) was up 7.5% during mid-day trading on Wednesday . The stock traded as high as $12.75 and last traded at $12.71. Approximately 31,560 shares were traded during trading, a decline of 92% from the average daily volume of 404,084 shares. The stock had previously closed at $11.82. […]

Analysts Offer Predictions for Y-mAbs Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:YMAB)

Analysts Offer Predictions for Y-mAbs Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:YMAB)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Down 3 2%

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Down 3 2%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.